Amerant Bancorp rescheduled results ‘concerning development’, says Piper Sandler

Piper Sandler keeps an Overweight rating and $26 price target on Amerant Bancorp (AMTB) but notes that the company’s announcement to reschedule results is a “somewhat concerning development”. There could be a credit hiccup and there is concern this delay could be an indicator of a broader accounting or credit issue, the analyst tells investors in a research note.